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We recently demonstrated strong genetic linkage 
between the type VII collagen gene (COL7A1) and 
both the dominant and recessive forms of dystrophic 
epidermolysis bullosa. In this study, we searched for 
mutations in dominant dystrophic epidermolysis bul-
losa using polymerase chain reaction amplification of 
segments of COL 7 A1, followed by heteroduplex anal-
ysis. Examination of the polymerase chain reaction 
corresponding to exon 73 revealed a heteroduplex 
pidermolysis bullosa (EB) is a group of mechano-
bullous diseases characterized by blistering of the skin 
and the mucous membranes as a result of minor trauma 
[1-3]. The diagnostic hallmark of the dystrophic forms 
....... of EB is abnormalities in the anchoring fibrils, attach-
ment structures at the dermo-epidermal junction, including mor-
phologic alterations, scarcity, or even complete absence [4]. Type 
VII collagen is the major, if not the exclusive, component of the 
anchoring fibrils [5]. We recently cloned the entire human type VII 
collagen cDNA [6] and gene [7] and mapped COL7A1 to chromo-
somal locus 3p21 [8]. Using intragenic and flanking restriction 
fragment length polymorphisms, we and others demonstrated 
strong genetic linkage between COL7 A1 and both the dominantly 
and recessively inherited forms of dystrophic EB, without evidence 
for locus heterogeneity (for review, see [9]). In fact, in dominant 
dystrophic EB (DDEB) , the cumulative LOD score (ZmaJ was 
greater than 44 in 14 unrelated families, providing overwhelming 
genetic linkage data in support of COL7 A1 as the candidate gene 
for mutations in DDEB [9]. We recently reported the first identi-
fication of a glycine substitution in COL7A1 in a large Finnish 
family with DDEB [10]. In this study, we report the identification 
of a distinct glycine substitution in COL7A1 in an Italian family 
with DDEB. 
MATERIALS AND METHODS 
peR Atnplification and Heteroduplex Analyses We studied an 
Italian family with clinical, histopathologic , and ultrastructural features of 
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resulting from a G-to-A transition at nucleotide 6127 
in the triple-helical domain of COL7A1, which con-
verted a glycine residue to an arginine (G2043R). The 
dominant dystrophic epidermolysis bullosa pheno-
type in this family probably arose because of a dom-
inant negative effect of this mutation in COL7A1, 
resulting in the formation of structurally abnormal 
anchoring fibrils. Key words: anchoring fibrils/COL7A1 
mutations. J Invest Dermatol 104:438-440, 1995 
DDEB (Fig 1). Electron microscopy revealed sub- lamina densa blister 
separation with a significantly reduced number of anchoring fibrils , which 
were sparse and hypoplastic . DNA isolated from peripheral blood lympho-
cytes of two affected and two unaffected family members was used as a 
template for amplification of genomic sequences within COL 7 A 1. For this 
purpose, oligonucleotide primers were synthesized on the basis of intronic 
sequences to generate approximately 300 base pair (bp) products, which 
cover the entire coding sequence of COL7Al. This sequence information 
has been deposited in the GenBank data base under accession no . L23982. 
The primers used to amplify the 287-bp fragment containing exon 73 were: 
upstream primer, 5 'GGGTGTAGCTGTACAGCCAC3 '; and downstream 
primer, S' CCCTCTTCCCTCACTCTCCT3' . 
For polymerase chain reaction (PCR) amplification, approximately 500 
ng of genomic DNA was used as template. The amplification conditions 
were 94°C for 7 min, followed by 94°C for 45 seconds, 55°C for 45 
seconds, and 72°C for 45 seconds, for 40 cycles, in an OmniGene thermal 
cycler (Marsh Scientific, Inc.). Amplification buffer contained 1.5 mM 
MgC12 and 2 U of Taq DNA polymerase (Gibco, BRL), in a total volume 
of 50 J.Ll. Aliquots of 5 J.LI were analyzed on 1.0% agarose gel electrophore-
sis, and 10 J.LI of the sample was prepared for heteroduplex analysis [11] 
according to the manufacturer's recommendations (MDE, AT Biochemi-
cals). Heteroduplexes were visualized by staining with ethidium bromide. 
Bands of altered mobility detected in heteroduplex analysis were sequenced 
directly using the ABI automated sequencing system. 
Verification of the Mutation The mutation detected 111 the PCR 
product containing exon 73 was verified at the genomic level. For this 
purpose, we searched for a potential change in restriction endonuclease sites 
as a result of the mutation and identified a deleted restriction site for Sma!. 
DNA in the region of the mutation was amplified by PCR using the same 
primers indicated above, and the products were cleaved with SmaI accord-
ing to the manufacturer's recommendations (New England Biolabs) and 
electrophoresed on 4% NuSieve agarose. The individuals bearing the 
G2043R mutation were heterozygous for a 138-bp fragment (resulting from 
the loss of the 93-bp and 45-bp fragments) and for the 93- and 45-bp 
cleaved fragments, whereas unaffected individuals showed only the 93- and 
45-bp fragments. A constant 149-bp band was observed in all individuals 
(see Results). 
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RESULTS 
We studied an Italian pedigree with DDEB, consisting of six 
affected and three unaffected living individuals in three generations 
(Fig 1). To identify the mutation in this family, we amplified 
genomic DNA segments by PCR and subjected the products to 
heteroduplex analysis. Examination of a PCR product spanning 
ex on 73 of COL7 A1 demonstrated a band of altered mobility in 
affected individuals, as compared with unaffected family members 
or unrelated healthy individuals (Fig 2A). Automated sequencing 
of PCR products from normal individuals of the family demon-
strated the presence of a G in nucleotide position 6127 in all cases. 
In contrast, sequencing of PCR products containing the mutant 
allele from affected individuals of the family demonstrated a 
heterozygous G-to-A transition (Fig 3). This nucleotide change 
resulted in substitution of a glycine (GGG) by an arginine (AGG) at 
amino acid position 2043 in one of the COL 7 Ai alleles. All affected 
individuals were heterozygous for this mutation, designated 
G2043R. 
Substitution of the first G in the recognition sequence for the 
endonuclease SmaI, CCCGGG, by an A abolished this restriction 
enzyme site. To examine the cosegregation of this mutation in the 
family and to verify its presence in genomic DNA, we performed 
SmaI digestions on the family members. The results indicated that 
individuals with altered mobility of this PCR product in heterodu-
pie x analysis were heterozygous for an allele undigestible with 
SmaI, bearing the G-to-A transition (Fig 2B). In addition, SmaI 
digestion of PCR-amplified DNA from 22 COL7A1 alleles from 
unrelated, ethnically matched individuals demonstrated the absence 
of the mutation G2043R. Furthermore, this mutation was not 
present in over 80 unrelated patients with different forms of 
dystrophic EB from varying ethnic backgrounds. These observa-
tions suggest that G2043R is not a common polymorphism and is 
not a prevalent mutation in other EB families. 
DISCUSSION 
The results of this study demonstrate that DNA from affected 
individuals in a pedigree with DDEB contains a heterozygous 
G2043R mutation in COL7A1, the locus to which DDEB previ-
ously had been linked [9,12,13]. It was detected only in the affected 
family members, whereas unaffected family members, 11 ethnically 
matched healthy individuals, and more than 80 unrelated dystro-
phic EB patients of varying ethnic backgrounds did not demonstrate 
this mutation. These observations suggest that the mutation 
G2043R is the underlying cause of DDEB in this family. 
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Figure 2. Heteroduplex analysis and verification of the mutation 
by restriction enzyme analysis. DNA sequences containing exon 73 
were amplified by peR, as described in the text, and the peR products 
were examined by heteroduplex analysis. Note a heteroduplex in the 
affected individuals IV -3 and 1II-3 (lal1 es 2 and 4), whereas the unaffected 
individuals IV -4 and III-4 (lanes 1 and 3), as shown in the nuclear pedigree 
(top), did not demonstrate the heteroduplex (A). The same peR products 
were digested with restriction enzyme SmaI (B). In affected individuals, a 
138-bp fragment is seen, which reflects a loss of the SmaI restriction enzyme 
site due to the G-to-A transition. Thus, the affected individuals are 
heterozygous for the uncleaved 138-bp band, which in the allele not 
containing the mutation is digested in heterozygotes to 93-bp and 45-bp 
bands (not shown) . All individuals also contain a constant 149-bp band. 
The collagenous domain of type VII collagen normally contains 
19 imperfections or interruptions in the characteristic collagenous 
Gly-X-Y amino acid repeat. The Gly-to-Arg substitution in this 
family occurs 65 amino acids downstream from the major nonhe-
lical 39 amino acid interruption (interruption 10) within the 
collagenous domain, in the Gly-X-Y repeat adjacent to the previ-
ously reported glycine substitution, G2040S [10]. We speculate that 
the stability of the triple-helical domains, although interspersed 
with nonhelical interruptions, is critical for the function of type VII 
collagen. In support of this suggestion are preliminary observations 
that the amino acid sequences of type VII collagen are not well 
conserved through evolution, yet the positions of the imperfections 
and interruptions are well conserved [14]. Therefore, we believe 
that a specific domain organization is necessary for the functional 
integrity of type VII collagen molecules in anchoring fibrils. 
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Figure 3. Automated sequencing of the peR products using the 
upstream primer. The primer is described in the Methods. Note a double 
peak (G + A, solid arrow) in an individual heterozygous for the substitution of 
G to A in the mutant allele, resulting in the mutation G2043R. The peak 
corresponding to the normal allele (G only) is also indicated (open arrow) . 
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